Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19-Reference-Cited by-同舟云学术

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19

Published:2020-07-28 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Cadegiani Flavio A.,Wambier Carlos G.,Goren Andy

Publisher

Frontiers Media SA

Subject

General Medicine

Reference91 articles.

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

2. The incubation period of Coronavirus Disease (2019) (COVID-19) from publicly reported confirmed cases: estimation and application;Lauer;Ann Intern Med,2020

3. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019. Pneumonia in Wuhan, China;Wu;JAMA Intern Med.,2020

4. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease;Liu;Chin Med J.,2020

5. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?;Fang;Lancet Respir Med.,2020

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of the Course of Arterial Hypertension in the Era of the COVID-19 Pandemic: Common Pathogenetic Links Between Hypertension and SARS-CoV-2;Kardiologiia;2024-04-30

2. Alkalinization Using Sodium Bicarbonate for COVID-19 Treatment: A Systematic Review and Meta-Analysis;Journal of Evidence-Based Integrative Medicine;2024-01

3. New insights on the potential effect of progesterone in Covid‐19: Anti‐inflammatory and immunosuppressive effects;Immunity, Inflammation and Disease;2023-11

4. Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition;Frontiers in Pharmacology;2023-08-03

5. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery;Genes & Diseases;2023-07